Header Logo

Sonal Singh

Concepts (660)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Disease, Chronic Obstructive
15
2014
283
3.860
Why?
Hypoglycemic Agents
15
2021
211
3.800
Why?
Diabetes Mellitus, Type 2
19
2018
676
3.510
Why?
Cough
13
2021
177
3.500
Why?
Thiazolidinediones
10
2015
50
3.060
Why?
Cardiovascular Diseases
15
2017
803
2.640
Why?
Scopolamine Derivatives
9
2014
10
2.600
Why?
Drug-Related Side Effects and Adverse Reactions
6
2024
147
2.440
Why?
Warfare
12
2014
32
2.160
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2019
219
2.150
Why?
Gastrointestinal Hemorrhage
5
2020
82
2.080
Why?
Humans
181
2024
57836
2.060
Why?
Cholinergic Antagonists
6
2014
25
2.020
Why?
Randomized Controlled Trials as Topic
25
2024
643
1.990
Why?
Pancreatitis
7
2015
100
1.930
Why?
Drugs, Generic
3
2018
17
1.810
Why?
Alzheimer Disease
3
2024
496
1.650
Why?
Algorithms
6
2022
975
1.500
Why?
Dabigatran
5
2023
22
1.490
Why?
Decision Support Techniques
5
2020
170
1.490
Why?
Delivery of Health Care
7
2021
416
1.450
Why?
Adverse Drug Reaction Reporting Systems
4
2017
48
1.440
Why?
Adrenal Cortex Hormones
5
2018
136
1.340
Why?
Pneumonia
6
2018
260
1.310
Why?
Anticoagulants
10
2023
487
1.310
Why?
Research Design
11
2023
571
1.210
Why?
Benzazepines
3
2012
22
1.200
Why?
Quinoxalines
3
2012
34
1.170
Why?
Bronchodilator Agents
4
2014
52
1.160
Why?
Myocardial Ischemia
3
2014
105
1.150
Why?
Aortic Aneurysm
2
2018
83
1.140
Why?
United States Food and Drug Administration
5
2018
93
1.140
Why?
Myocardial Infarction
9
2018
868
1.140
Why?
Clinical Trials as Topic
9
2018
415
1.110
Why?
Administration, Inhalation
12
2014
91
1.100
Why?
Evidence-Based Medicine
8
2019
449
1.070
Why?
Atrial Fibrillation
6
2023
719
1.030
Why?
Warfarin
6
2015
109
1.010
Why?
Risk Assessment
19
2020
1891
0.980
Why?
Renal Insufficiency
2
2023
60
0.960
Why?
Male
52
2024
26660
0.950
Why?
Glucagon-Like Peptide 1
3
2018
17
0.940
Why?
Aged
35
2024
12844
0.920
Why?
Ipratropium
3
2014
7
0.910
Why?
Anti-Bacterial Agents
4
2018
660
0.900
Why?
Human Rights
5
2008
16
0.900
Why?
Female
58
2024
30120
0.900
Why?
Nicotinic Agonists
3
2012
40
0.890
Why?
Asthma
2
2022
430
0.860
Why?
Primary Prevention
3
2019
134
0.850
Why?
Electronic Health Records
3
2022
339
0.840
Why?
Periodicals as Topic
2
2020
165
0.830
Why?
Anti-Asthmatic Agents
1
2022
43
0.820
Why?
Prescription Drugs
3
2018
50
0.810
Why?
Renal Insufficiency, Chronic
1
2023
107
0.800
Why?
Review Literature as Topic
5
2016
37
0.780
Why?
Heart Failure
7
2016
828
0.780
Why?
Biological Products
1
2022
92
0.770
Why?
Adult
34
2024
15396
0.760
Why?
Antiparkinson Agents
1
2021
8
0.760
Why?
Dopamine Antagonists
1
2021
15
0.760
Why?
Fluoroquinolones
2
2018
26
0.750
Why?
HIV Infections
9
2017
914
0.720
Why?
Public Health
3
2007
179
0.710
Why?
Nepal
13
2016
93
0.710
Why?
Tiotropium Bromide
8
2014
10
0.700
Why?
Vaccination Coverage
1
2019
6
0.700
Why?
Intracranial Hemorrhages
1
2020
51
0.700
Why?
Hospitalization
5
2022
1252
0.690
Why?
Middle Aged
36
2024
15729
0.690
Why?
Pharmaceutical Preparations
1
2021
122
0.690
Why?
Practice Guidelines as Topic
6
2018
704
0.690
Why?
Wernicke Encephalopathy
4
2007
4
0.680
Why?
Risk Factors
20
2018
4930
0.670
Why?
Treatment Outcome
17
2023
4912
0.670
Why?
Testosterone
2
2016
133
0.670
Why?
Drug Prescriptions
1
2021
188
0.660
Why?
Human Rights Abuses
3
2007
3
0.650
Why?
Glucocorticoids
2
2011
161
0.650
Why?
Cardiovascular System
1
2019
38
0.650
Why?
beta-Alanine
2
2015
8
0.640
Why?
Myocarditis
1
2019
45
0.640
Why?
Death, Sudden, Cardiac
2
2019
297
0.640
Why?
Immunologic Factors
1
2019
99
0.640
Why?
Refugees
4
2008
61
0.630
Why?
Urinary Bladder Neoplasms
2
2015
53
0.630
Why?
Patient Participation
1
2020
210
0.620
Why?
Thiophenes
2
2015
41
0.620
Why?
Antibodies, Monoclonal, Humanized
1
2020
209
0.620
Why?
Databases, Factual
5
2021
839
0.620
Why?
Cause of Death
3
2019
197
0.620
Why?
Morpholines
2
2015
84
0.620
Why?
Stroke
6
2023
1108
0.620
Why?
Decision Making
3
2018
383
0.620
Why?
Statistics as Topic
1
2018
151
0.610
Why?
Benzimidazoles
2
2015
58
0.610
Why?
United States
18
2023
7388
0.610
Why?
Amphetamine
1
2017
11
0.600
Why?
Early Detection of Cancer
1
2020
253
0.600
Why?
Herpes Zoster
1
2017
22
0.590
Why?
Thyroxine
1
2017
54
0.580
Why?
Guidelines as Topic
4
2012
160
0.580
Why?
Incretins
1
2016
5
0.570
Why?
Atherosclerosis
1
2018
144
0.570
Why?
Incidence
9
2022
1216
0.570
Why?
Cerebrovascular Disorders
1
2017
70
0.570
Why?
Antithrombins
1
2017
15
0.560
Why?
Disasters
2
2014
28
0.550
Why?
Lung Neoplasms
2
2020
532
0.540
Why?
Bronchitis
2
2020
23
0.530
Why?
Health Services Accessibility
6
2009
532
0.530
Why?
Pharyngitis
2
2006
12
0.520
Why?
Streptococcus pyogenes
2
2006
27
0.520
Why?
Arrhythmias, Cardiac
2
2016
134
0.520
Why?
Rhabdomyolysis
2
2006
26
0.510
Why?
Fluorobenzenes
2
2005
5
0.510
Why?
Streptococcal Infections
2
2006
77
0.510
Why?
Pharmacoepidemiology
1
2014
12
0.500
Why?
Vena Cava Filters
2
2014
21
0.490
Why?
Fractures, Bone
3
2011
149
0.490
Why?
Risk
7
2020
374
0.490
Why?
Heptanoic Acids
2
2004
20
0.490
Why?
Pyrroles
2
2004
48
0.480
Why?
Pyrimidines
2
2005
116
0.480
Why?
Sulfonamides
2
2005
124
0.470
Why?
Embolism, Paradoxical
1
2014
12
0.460
Why?
Developing Countries
4
2008
80
0.460
Why?
Aged, 80 and over
12
2021
4913
0.460
Why?
Medication Adherence
2
2015
262
0.460
Why?
Bariatric Surgery
3
2013
43
0.460
Why?
Urinary Retention
2
2011
29
0.450
Why?
Azasteroids
1
2013
2
0.450
Why?
5-alpha Reductase Inhibitors
1
2013
6
0.450
Why?
Health Planning Guidelines
1
2013
33
0.450
Why?
Valproic Acid
1
2013
24
0.450
Why?
Age Factors
8
2021
1537
0.440
Why?
Consensus
3
2018
178
0.440
Why?
Relief Work
3
2007
13
0.440
Why?
Tomography, X-Ray Computed
1
2020
1340
0.440
Why?
Dose-Response Relationship, Drug
6
2014
802
0.440
Why?
Biomedical Research
3
2013
241
0.430
Why?
Meta-Analysis as Topic
5
2015
76
0.430
Why?
Child Development Disorders, Pervasive
1
2013
52
0.430
Why?
Anticonvulsants
1
2013
92
0.430
Why?
Prostatic Neoplasms
1
2015
319
0.430
Why?
Insulin
1
2016
696
0.420
Why?
Diagnostic Techniques and Procedures
1
2012
8
0.420
Why?
Epilepsy
1
2013
99
0.410
Why?
Tobacco Use Cessation
1
2012
30
0.410
Why?
Polypharmacy
2
2024
63
0.410
Why?
Macular Edema
1
2012
24
0.410
Why?
Pancreatic Neoplasms
1
2015
319
0.410
Why?
Cohort Studies
5
2021
2381
0.400
Why?
Bupropion
1
2011
8
0.400
Why?
Chronic Disease
6
2021
735
0.400
Why?
Acute Disease
6
2020
671
0.400
Why?
Prenatal Exposure Delayed Effects
1
2013
164
0.400
Why?
Diabetic Angiopathies
2
2008
24
0.390
Why?
Mucociliary Clearance
1
2021
5
0.390
Why?
Reflex
1
2021
28
0.380
Why?
Venoms
3
2016
11
0.380
Why?
Administration, Oral
5
2023
342
0.380
Why?
Wounds and Injuries
1
2014
241
0.380
Why?
Opportunistic Infections
1
2011
27
0.380
Why?
Dipeptidyl-Peptidase IV Inhibitors
4
2021
10
0.380
Why?
Autistic Disorder
1
2013
164
0.370
Why?
Nicotine
1
2011
110
0.370
Why?
Product Surveillance, Postmarketing
4
2012
22
0.360
Why?
Respiratory Tract Infections
1
2011
77
0.360
Why?
Bronchitis, Chronic
1
2020
4
0.360
Why?
Reproducibility of Results
4
2022
1514
0.360
Why?
Lower Extremity
3
2021
143
0.350
Why?
Eosinophilia
1
2020
25
0.350
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2011
199
0.350
Why?
Quality of Life
3
2020
1023
0.350
Why?
Retrospective Studies
10
2023
5749
0.350
Why?
Suicide
1
2011
121
0.350
Why?
Child
11
2020
4312
0.340
Why?
Outpatients
2
2020
131
0.340
Why?
International Cooperation
5
2008
84
0.340
Why?
Glucagon-Like Peptide-1 Receptor
2
2021
15
0.340
Why?
Mortality
3
2018
154
0.340
Why?
Postoperative Complications
4
2013
1079
0.330
Why?
Kidney Failure, Chronic
2
2008
187
0.330
Why?
Observational Studies as Topic
3
2019
54
0.330
Why?
Diphosphonates
1
2009
35
0.330
Why?
Outsourced Services
1
2008
3
0.330
Why?
Health
2
2006
33
0.330
Why?
Polyethylene Glycols
2
2023
163
0.320
Why?
Whooping Cough
1
2018
15
0.320
Why?
Gastroesophageal Reflux
1
2019
72
0.320
Why?
Depression
3
2014
872
0.320
Why?
Bone Density Conservation Agents
1
2009
51
0.320
Why?
Publication Bias
4
2012
21
0.320
Why?
Emigration and Immigration
2
2008
25
0.320
Why?
Pregnancy Complications
1
2013
398
0.320
Why?
Bronchiolitis, Viral
1
2018
4
0.320
Why?
Patient Education as Topic
2
2011
454
0.310
Why?
Disaster Planning
3
2015
50
0.310
Why?
Stomatitis
1
2008
6
0.310
Why?
Simvastatin
2
2005
29
0.310
Why?
Lung Diseases, Interstitial
1
2018
48
0.310
Why?
Attitude to Health
2
2008
285
0.300
Why?
Antiviral Agents
2
2023
317
0.300
Why?
Adolescent
9
2020
5912
0.300
Why?
Hemorrhage
3
2023
275
0.300
Why?
Secondary Prevention
2
2019
149
0.300
Why?
Interferon-alpha
1
2008
99
0.300
Why?
Patient Advocacy
1
2007
29
0.290
Why?
Civil Disorders
1
2007
2
0.290
Why?
Peptides
3
2016
546
0.290
Why?
Lisinopril
1
2006
4
0.290
Why?
Child Welfare
2
2009
55
0.280
Why?
Young Adult
7
2021
4205
0.280
Why?
Contrast Media
2
2008
388
0.280
Why?
Critical Illness
1
2020
324
0.280
Why?
Mass Screening
2
2017
629
0.280
Why?
Renal Dialysis
1
2008
187
0.280
Why?
Sample Size
4
2023
59
0.270
Why?
Tuberculosis, Pulmonary
1
2017
104
0.270
Why?
Information Dissemination
1
2007
112
0.270
Why?
Amiodarone
1
2006
18
0.270
Why?
Pulmonary Alveoli
1
2006
41
0.270
Why?
Influenza, Human
1
2018
186
0.270
Why?
Hydralazine
1
2006
1
0.270
Why?
Clinical Clerkship
1
2006
83
0.270
Why?
Smoking Cessation
1
2011
544
0.270
Why?
Self Care
1
2008
209
0.270
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2006
142
0.270
Why?
Anti-Arrhythmia Agents
1
2006
65
0.260
Why?
Vasodilator Agents
1
2006
57
0.260
Why?
Internal Medicine
1
2006
146
0.260
Why?
Vasoconstrictor Agents
1
2006
61
0.260
Why?
Myelography
1
2005
1
0.260
Why?
Religion and Medicine
1
2005
23
0.260
Why?
Iopamidol
1
2005
16
0.260
Why?
Cocaine-Related Disorders
1
2006
74
0.250
Why?
Patient Selection
5
2015
424
0.250
Why?
Aging
1
2021
720
0.250
Why?
Bariatrics
1
2005
1
0.250
Why?
Religion
1
2005
34
0.250
Why?
Aminopyridines
2
2016
21
0.250
Why?
Carotid Stenosis
1
2006
99
0.250
Why?
Pharynx
1
2005
20
0.250
Why?
Cocaine
1
2006
85
0.250
Why?
Benzamides
2
2016
49
0.250
Why?
Peripheral Nervous System Diseases
1
2005
27
0.250
Why?
Disease Outbreaks
1
2005
103
0.250
Why?
Formularies as Topic
1
2004
2
0.250
Why?
Patient-Centered Care
2
2019
242
0.250
Why?
Community Health Services
1
2006
134
0.250
Why?
Lung Diseases
1
2006
145
0.240
Why?
Referral and Consultation
1
2008
399
0.240
Why?
Social Justice
1
2004
31
0.240
Why?
Follow-Up Studies
4
2018
2238
0.240
Why?
Seizures
1
2005
111
0.240
Why?
Societies, Medical
1
2006
306
0.240
Why?
Lupus Erythematosus, Systemic
1
2006
156
0.240
Why?
Kidney Transplantation
1
2006
254
0.240
Why?
Healthcare Disparities
1
2008
330
0.230
Why?
Antipsychotic Agents
2
2015
311
0.230
Why?
Acute Kidney Injury
1
2006
126
0.230
Why?
Potentially Inappropriate Medication List
1
2024
14
0.230
Why?
Bias
3
2014
110
0.230
Why?
Drug Therapy, Combination
5
2018
418
0.230
Why?
Drug Administration Schedule
3
2014
279
0.230
Why?
Health Services
1
2004
87
0.230
Why?
Vaccination
5
2024
323
0.230
Why?
Tenofovir
1
2023
8
0.220
Why?
Health Knowledge, Attitudes, Practice
2
2009
736
0.220
Why?
Obesity
2
2013
1221
0.220
Why?
Inappropriate Prescribing
1
2024
63
0.220
Why?
Socioeconomic Factors
5
2016
794
0.220
Why?
Qualitative Research
3
2024
570
0.220
Why?
Adenine
1
2023
43
0.220
Why?
Heart Transplantation
1
2004
144
0.220
Why?
Child Abuse
1
2004
88
0.220
Why?
Rivaroxaban
3
2023
19
0.220
Why?
Physicians
3
2022
440
0.220
Why?
Military Personnel
1
2004
97
0.220
Why?
Blood Glucose
3
2018
482
0.220
Why?
Focus Groups
1
2024
291
0.210
Why?
Health Expenditures
1
2004
110
0.210
Why?
Acquired Immunodeficiency Syndrome
3
2009
138
0.210
Why?
Intracranial Aneurysm
1
2006
293
0.210
Why?
Ivermectin
1
2022
10
0.210
Why?
Dementia
1
2005
232
0.210
Why?
Influenza Vaccines
1
2023
85
0.200
Why?
Kidney
2
2023
387
0.200
Why?
Varenicline
2
2011
12
0.200
Why?
Caregivers
1
2024
211
0.200
Why?
Hypertension
1
2007
603
0.200
Why?
International Classification of Diseases
2
2019
143
0.190
Why?
Venous Thromboembolism
2
2013
155
0.190
Why?
Medication Systems
1
2021
18
0.190
Why?
Double-Blind Method
3
2023
641
0.190
Why?
Communication
3
2024
523
0.190
Why?
Pilot Projects
3
2017
893
0.190
Why?
Delphi Technique
3
2019
76
0.190
Why?
Diuretics
1
2021
58
0.190
Why?
Calcium Channel Blockers
1
2021
53
0.190
Why?
Pharmacy
1
2021
18
0.190
Why?
Data Collection
2
2019
392
0.190
Why?
Ambulatory Care
3
2023
285
0.180
Why?
Proton Pump Inhibitors
2
2019
36
0.180
Why?
Case-Control Studies
3
2013
1030
0.180
Why?
Medication Errors
1
2021
114
0.180
Why?
Anti-Infective Agents
1
2022
133
0.180
Why?
Severity of Illness Index
2
2020
1385
0.180
Why?
Safety Management
2
2012
144
0.180
Why?
Vaccines
1
2021
96
0.180
Why?
Drug Labeling
2
2012
28
0.180
Why?
Primary Health Care
2
2024
630
0.180
Why?
Peripheral Arterial Disease
2
2020
147
0.180
Why?
Prevalence
5
2013
1269
0.170
Why?
Pharmacists
1
2021
123
0.170
Why?
Death Certificates
1
2019
9
0.170
Why?
Prognosis
3
2014
1505
0.170
Why?
Patient Safety
2
2012
234
0.170
Why?
Vulnerable Populations
2
2013
82
0.170
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
33
0.170
Why?
Medicare
1
2023
583
0.160
Why?
Reminder Systems
1
2019
72
0.160
Why?
Canagliflozin
1
2018
4
0.160
Why?
Armed Conflicts
1
2018
3
0.160
Why?
Health Status
2
2016
441
0.160
Why?
Exposure to Violence
1
2018
5
0.160
Why?
Data Interpretation, Statistical
3
2015
198
0.160
Why?
Health Facilities
1
2018
42
0.150
Why?
Comparative Effectiveness Research
3
2013
44
0.150
Why?
Quality Control
1
2018
69
0.150
Why?
Education
1
2018
75
0.150
Why?
Health Education
1
2019
187
0.150
Why?
Osteoporotic Fractures
1
2018
35
0.150
Why?
Multiple Chronic Conditions
1
2018
36
0.150
Why?
Budesonide
2
2023
11
0.150
Why?
Cooperative Behavior
1
2019
218
0.150
Why?
Respiratory Function Tests
2
2009
114
0.150
Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.150
Why?
Torture
2
2008
2
0.150
Why?
Metformin
2
2015
69
0.150
Why?
Crime Victims
1
2018
50
0.150
Why?
Population Surveillance
1
2018
210
0.150
Why?
Practice Patterns, Physicians'
2
2021
733
0.140
Why?
Insulin Detemir
1
2016
1
0.140
Why?
Glucagon-Like Peptides
1
2016
1
0.140
Why?
Insulin Glargine
1
2016
2
0.140
Why?
Insulin, Long-Acting
1
2016
2
0.140
Why?
Liraglutide
1
2016
4
0.140
Why?
Observer Variation
1
2017
193
0.140
Why?
Medical Records
1
2017
134
0.140
Why?
Stress, Psychological
2
2014
440
0.140
Why?
Cross-Sectional Studies
3
2019
2416
0.140
Why?
Hormone Replacement Therapy
1
2016
37
0.140
Why?
Thiamine Deficiency
2
2007
5
0.140
Why?
Androgens
1
2016
56
0.140
Why?
Immunoglobulin Fc Fragments
1
2016
48
0.140
Why?
Antiretroviral Therapy, Highly Active
2
2006
98
0.140
Why?
China
2
2008
136
0.140
Why?
Drug Evaluation
1
2016
20
0.140
Why?
Widowhood
1
2016
4
0.140
Why?
Surge Capacity
1
2015
1
0.130
Why?
Social Isolation
1
2016
29
0.130
Why?
Hypoglycemia
1
2016
68
0.130
Why?
Drug Interactions
2
2007
112
0.130
Why?
Research
2
2015
193
0.130
Why?
Registries
1
2019
805
0.130
Why?
Sensitivity and Specificity
3
2014
1054
0.130
Why?
Insurance Claim Review
1
2015
81
0.130
Why?
Rosuvastatin Calcium
2
2005
3
0.130
Why?
Checklist
1
2016
74
0.130
Why?
Hospital Mortality
1
2020
872
0.130
Why?
Altruism
1
2014
13
0.120
Why?
Adrenomedullin
1
2014
1
0.120
Why?
Comorbidity
1
2018
1091
0.120
Why?
Recombinant Fusion Proteins
1
2016
501
0.120
Why?
Publishing
1
2016
87
0.120
Why?
Cognitive Dysfunction
1
2018
250
0.120
Why?
Multiple Myeloma
1
2019
312
0.120
Why?
Protein Precursors
1
2014
71
0.120
Why?
Violence
2
2007
185
0.120
Why?
Health Services Needs and Demand
2
2007
210
0.120
Why?
Aspirin
1
2015
189
0.120
Why?
Phosphodiesterase 4 Inhibitors
1
2013
2
0.120
Why?
Health Services Research
1
2015
274
0.120
Why?
Bibliometrics
1
2013
26
0.120
Why?
Patient Compliance
2
2006
379
0.110
Why?
Dutasteride
1
2013
1
0.110
Why?
Prostatic Diseases
1
2013
5
0.110
Why?
Pakistan
1
2013
14
0.110
Why?
Publications
1
2013
27
0.110
Why?
Sitagliptin Phosphate
1
2013
2
0.110
Why?
Time Factors
3
2011
3508
0.110
Why?
Sex Workers
1
2013
16
0.110
Why?
Meditation
1
2014
59
0.110
Why?
Diabetes Mellitus
1
2018
541
0.110
Why?
Bone Density
2
2018
178
0.110
Why?
Emergency Medicine
1
2015
180
0.110
Why?
Tetrabenazine
1
2013
1
0.110
Why?
Adrenergic Uptake Inhibitors
1
2013
14
0.110
Why?
Pyrazines
1
2013
32
0.110
Why?
Drug Recalls
1
2012
1
0.110
Why?
Affect
1
2014
124
0.110
Why?
Triazoles
1
2013
55
0.110
Why?
Social Support
1
2016
366
0.110
Why?
Prospective Studies
2
2017
2999
0.110
Why?
Substance Abuse, Intravenous
1
2013
73
0.110
Why?
Therapeutic Equivalency
1
2012
9
0.110
Why?
Endpoint Determination
1
2012
21
0.110
Why?
Risk Reduction Behavior
1
2013
129
0.100
Why?
Histamine H2 Antagonists
1
2012
10
0.100
Why?
Neoplasms
2
2015
1179
0.100
Why?
Bayes Theorem
2
2023
106
0.100
Why?
Enterocolitis, Pseudomembranous
1
2012
32
0.100
Why?
MP3-Player
1
2011
2
0.100
Why?
Suicidal Ideation
1
2013
113
0.100
Why?
Androstadienes
1
2011
13
0.100
Why?
Emergency Service, Hospital
1
2019
986
0.100
Why?
Fluticasone
1
2011
6
0.100
Why?
Huntington Disease
1
2013
146
0.100
Why?
Neuromuscular Diseases
1
2021
20
0.100
Why?
Platelet Aggregation Inhibitors
1
2013
238
0.100
Why?
Health Care Rationing
2
2015
20
0.090
Why?
Survival Analysis
1
2012
553
0.090
Why?
Salmeterol Xinafoate
1
2010
3
0.090
Why?
Observation
1
2010
26
0.090
Why?
Albuterol
1
2010
17
0.090
Why?
Reference Values
1
2011
329
0.090
Why?
Mental Disorders
2
2009
792
0.090
Why?
Patient Satisfaction
2
2011
415
0.090
Why?
Symptom Flare Up
1
2020
11
0.090
Why?
Biomechanical Phenomena
1
2021
257
0.090
Why?
Symptom Assessment
1
2020
41
0.090
Why?
Needs Assessment
2
2015
178
0.090
Why?
Technology, Pharmaceutical
1
2009
19
0.090
Why?
Quality Indicators, Health Care
1
2012
334
0.080
Why?
Respiratory Aspiration
1
2009
5
0.080
Why?
Logistic Models
1
2013
1267
0.080
Why?
Program Evaluation
2
2011
480
0.080
Why?
Anti-Retroviral Agents
1
2009
75
0.080
Why?
Sodium Bicarbonate
1
2008
11
0.080
Why?
Bronchoscopy
1
2009
56
0.080
Why?
Latin America
1
2008
14
0.080
Why?
Africa
1
2008
20
0.080
Why?
Drug Discovery
1
2009
83
0.080
Why?
Foreign Bodies
1
2009
42
0.080
Why?
Japan
1
2008
58
0.080
Why?
Russia
1
2008
53
0.080
Why?
Taiwan
2
2021
6
0.080
Why?
Sarcoidosis, Pulmonary
1
2018
9
0.080
Why?
Scleroderma, Systemic
1
2018
13
0.080
Why?
Thiamine
2
2007
19
0.080
Why?
Tibet
2
2006
2
0.080
Why?
Government Regulation
1
2008
44
0.080
Why?
Colorectal Neoplasms
1
2011
255
0.080
Why?
Research Support as Topic
1
2008
44
0.080
Why?
Drug Industry
1
2008
42
0.080
Why?
Odds Ratio
2
2008
805
0.080
Why?
Sex Factors
1
2021
951
0.080
Why?
Kidney Function Tests
1
2008
34
0.080
Why?
India
1
2008
154
0.080
Why?
Nephrology
1
2008
15
0.080
Why?
Sulfonylurea Compounds
2
2020
14
0.080
Why?
Recurrence
2
2012
552
0.080
Why?
Anti-HIV Agents
2
2006
152
0.080
Why?
Health Personnel
2
2018
357
0.080
Why?
Causality
1
2008
56
0.080
Why?
Cardiac Output, Low
1
2007
10
0.080
Why?
Postgastrectomy Syndromes
1
2007
4
0.080
Why?
Rwanda
1
2007
13
0.080
Why?
Malabsorption Syndromes
1
2007
4
0.080
Why?
Anecdotes as Topic
1
2007
10
0.080
Why?
Toxins, Biological
1
2007
6
0.070
Why?
New York City
1
2007
73
0.070
Why?
Patient Care Planning
1
2008
84
0.070
Why?
Catheters, Indwelling
1
2008
62
0.070
Why?
Osteoporosis
1
2009
145
0.070
Why?
Homicide
1
2007
27
0.070
Why?
Internet
1
2011
458
0.070
Why?
Homosexuality, Male
1
2007
35
0.070
Why?
Public Policy
1
2008
43
0.070
Why?
Health Policy
2
2008
180
0.070
Why?
Kidney Diseases
1
2008
152
0.070
Why?
Child, Preschool
2
2020
1852
0.070
Why?
Communicable Disease Control
1
2007
37
0.070
Why?
Anxiety
2
2014
397
0.070
Why?
Catheterization, Central Venous
1
2008
86
0.070
Why?
Theft
1
2006
3
0.070
Why?
Developed Countries
1
2006
14
0.070
Why?
Disease Susceptibility
1
2007
156
0.070
Why?
Communicable Diseases
1
2007
76
0.070
Why?
Safety
1
2007
142
0.070
Why?
Educational Status
1
2008
273
0.070
Why?
Minority Groups
1
2008
132
0.070
Why?
History, 21st Century
1
2007
162
0.070
Why?
Vascular Neoplasms
1
2006
15
0.070
Why?
HIV
1
2006
69
0.070
Why?
Infant Mortality
1
2006
20
0.070
Why?
Biomarkers
2
2014
1133
0.070
Why?
Police
1
2006
37
0.070
Why?
Expert Systems
1
2006
6
0.070
Why?
Life Change Events
1
2006
66
0.070
Why?
History, 20th Century
1
2007
236
0.070
Why?
Penicillins
1
2006
27
0.070
Why?
Guideline Adherence
1
2008
305
0.070
Why?
Ethics, Research
1
2006
19
0.070
Why?
Likelihood Functions
1
2006
74
0.070
Why?
Vasoconstriction
1
2006
18
0.070
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
61
0.070
Why?
Pregnancy
1
2013
2352
0.070
Why?
Endarterectomy, Carotid
1
2006
85
0.060
Why?
Recombinant Proteins
1
2008
687
0.060
Why?
AIDS Vaccines
1
2006
64
0.060
Why?
Maternal Health Services
1
2006
64
0.060
Why?
Child Health Services
1
2006
65
0.060
Why?
Condoms
1
2005
47
0.060
Why?
Thrombosis
1
2008
193
0.060
Why?
Decision Support Systems, Clinical
1
2006
68
0.060
Why?
Diabetic Nephropathies
1
2005
36
0.060
Why?
Patient Care Team
1
2008
305
0.060
Why?
Horner Syndrome
1
2005
1
0.060
Why?
Communism
1
2004
1
0.060
Why?
War Crimes
1
2004
2
0.060
Why?
Carotid Artery, Internal, Dissection
1
2005
11
0.060
Why?
Nutrition Disorders
1
2004
6
0.060
Why?
Educational Measurement
1
2006
202
0.060
Why?
Principle-Based Ethics
1
2004
2
0.060
Why?
Cyclopropanes
2
2016
39
0.060
Why?
Psychology, Child
1
2004
6
0.060
Why?
Resource Allocation
1
2004
18
0.060
Why?
Poverty
1
2007
295
0.060
Why?
Family Practice
1
2006
202
0.060
Why?
Infant
2
2006
1522
0.060
Why?
Rural Health
1
2004
15
0.060
Why?
Health Planning
1
2004
27
0.060
Why?
Malaria, Vivax
1
2005
33
0.060
Why?
Education, Medical
1
2006
172
0.060
Why?
Cyclosporine
1
2004
55
0.060
Why?
Total Quality Management
1
2004
57
0.060
Why?
Tachycardia, Ventricular
1
2006
95
0.060
Why?
Child Advocacy
1
2004
7
0.060
Why?
Drug Utilization
1
2006
229
0.060
Why?
Drug Delivery Systems
1
2008
299
0.060
Why?
Morbidity
1
2004
103
0.060
Why?
Massachusetts
2
2021
2134
0.060
Why?
Postoperative Care
1
2004
104
0.060
Why?
Gastric Bypass
1
2004
73
0.060
Why?
Medicaid
2
2019
340
0.060
Why?
Africa South of the Sahara
3
2009
16
0.060
Why?
Trust
1
2024
65
0.060
Why?
Pyridones
1
2023
28
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2023
4
0.060
Why?
Factor Xa Inhibitors
1
2023
35
0.060
Why?
Physicians, Primary Care
1
2024
73
0.060
Why?
Fluvoxamine
1
2023
1
0.060
Why?
Students, Medical
1
2006
238
0.060
Why?
Embolization, Therapeutic
1
2006
267
0.050
Why?
Diagnosis, Differential
1
2006
859
0.050
Why?
Injections, Subcutaneous
1
2023
71
0.050
Why?
Stents
1
2006
399
0.050
Why?
Immunosuppressive Agents
1
2004
279
0.050
Why?
Curriculum
1
2006
534
0.050
Why?
National Institutes of Health (U.S.)
1
2023
97
0.050
Why?
United States Agency for Healthcare Research and Quality
2
2012
30
0.050
Why?
Antineoplastic Agents
1
2008
627
0.050
Why?
Intention
1
2022
65
0.050
Why?
Infant, Newborn
1
2006
1303
0.050
Why?
Physician-Patient Relations
1
2024
380
0.050
Why?
Peripheral Vascular Diseases
1
2021
46
0.050
Why?
Liver
1
2005
754
0.050
Why?
Glucosides
1
2020
12
0.050
Why?
Attitude of Health Personnel
1
2024
551
0.040
Why?
Interviews as Topic
2
2016
471
0.040
Why?
Administrative Claims, Healthcare
1
2019
10
0.040
Why?
Tennessee
1
2019
16
0.040
Why?
Benzhydryl Compounds
1
2020
47
0.040
Why?
Clinical Competence
1
2004
640
0.040
Why?
Longitudinal Studies
1
2023
1208
0.040
Why?
Clinical Coding
1
2019
42
0.040
Why?
United Nations
2
2009
4
0.040
Why?
Government
1
2018
8
0.040
Why?
Bombs
1
2018
3
0.040
Why?
Syria
1
2018
12
0.040
Why?
Epidemiological Monitoring
1
2018
25
0.040
Why?
Propensity Score
1
2018
130
0.040
Why?
Mass Casualty Incidents
1
2018
30
0.040
Why?
Surveys and Questionnaires
2
2018
2553
0.040
Why?
Health Resources
1
2018
80
0.040
Why?
Predictive Value of Tests
1
2019
965
0.040
Why?
Cyclohexanecarboxylic Acids
1
2015
9
0.030
Why?
Consensus Development Conferences as Topic
1
2015
16
0.030
Why?
Quetiapine Fumarate
1
2015
13
0.030
Why?
Selection Bias
1
2015
27
0.030
Why?
Neuralgia
1
2015
20
0.030
Why?
Amines
1
2015
30
0.030
Why?
Heparin
2
2008
112
0.030
Why?
Disease Progression
1
2019
935
0.030
Why?
gamma-Aminobutyric Acid
1
2015
78
0.030
Why?
Analgesics
1
2015
98
0.030
Why?
Triage
1
2015
110
0.030
Why?
Community-Acquired Infections
1
2014
86
0.030
Why?
Placebos
1
2013
74
0.030
Why?
Adaptation, Psychological
1
2016
270
0.030
Why?
Enoxaparin
1
2013
17
0.030
Why?
Proportional Hazards Models
1
2015
668
0.030
Why?
Heparin, Low-Molecular-Weight
1
2013
29
0.030
Why?
Emotions
1
2016
221
0.030
Why?
Nasal Sprays
1
2012
2
0.030
Why?
Nebulizers and Vaporizers
1
2012
28
0.030
Why?
Bipolar Disorder
1
2015
252
0.030
Why?
Computer Graphics
1
2012
23
0.030
Why?
Critical Care
1
2015
400
0.020
Why?
International Normalized Ratio
1
2011
35
0.020
Why?
North Carolina
1
2011
62
0.020
Why?
Terminology as Topic
1
2012
135
0.020
Why?
Pulmonary Embolism
1
2013
184
0.020
Why?
Computer-Assisted Instruction
1
2011
75
0.020
Why?
Patient Preference
1
2011
75
0.020
Why?
Health Literacy
1
2011
77
0.020
Why?
Voluntary Health Agencies
1
2009
4
0.020
Why?
Rape
1
2009
15
0.020
Why?
Body Weight
1
2011
396
0.020
Why?
Sodium Chloride
1
2008
58
0.020
Why?
Age Distribution
1
2009
269
0.020
Why?
Lipids
1
2011
304
0.020
Why?
Sexual Behavior
1
2009
186
0.020
Why?
Infusions, Intravenous
1
2008
174
0.020
Why?
Bhutan
1
2008
20
0.020
Why?
Elephantiasis, Filarial
1
2007
9
0.020
Why?
Myanmar
1
2007
10
0.020
Why?
Yellow Fever
1
2007
3
0.020
Why?
Colombia
1
2007
14
0.020
Why?
Animals
1
2006
19324
0.020
Why?
Leishmaniasis, Cutaneous
1
2007
12
0.020
Why?
Half-Life
1
2007
67
0.020
Why?
Chagas Disease
1
2007
34
0.020
Why?
Thrombocytopenia
1
2008
53
0.020
Why?
Hunger
1
2006
17
0.020
Why?
Time
1
2006
27
0.020
Why?
Social Welfare
1
2006
22
0.020
Why?
Leukocyte Common Antigens
1
2006
53
0.020
Why?
North America
1
2006
115
0.020
Why?
Coercion
1
2006
54
0.020
Why?
Fatal Outcome
1
2006
109
0.020
Why?
Lymphoma, B-Cell
1
2006
58
0.020
Why?
Multiple Organ Failure
1
2006
41
0.020
Why?
Clinical Trials Data Monitoring Committees
1
2006
5
0.020
Why?
Cambodia
1
2005
18
0.020
Why?
Confidentiality
1
2006
53
0.020
Why?
Self-Help Groups
1
2005
38
0.020
Why?
Attitude
1
2006
100
0.020
Why?
Prisons
1
2006
113
0.020
Why?
Quinine
1
2005
3
0.020
Why?
Chloroquine
1
2005
48
0.020
Why?
Doxycycline
1
2005
38
0.020
Why?
Informed Consent
1
2006
130
0.020
Why?
Drug Resistance, Microbial
1
2005
42
0.020
Why?
Antimalarials
1
2005
67
0.020
Why?
Erythrocytes
1
2005
154
0.010
Why?
Stress Disorders, Post-Traumatic
1
2008
370
0.010
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (660)
Explore
_
Co-Authors (29)
Explore
_
Similar People (57)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_